Protagonist Therapeutics, Inc.
NASDAQ:PTGX
41.49 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -78.955 | -127.393 | -125.551 | -66.15 | -77.187 | -38.924 | -36.957 | -37.177 | -14.858 | -11.072 |
| Depreciation & Amortization
| 3.312 | 3.369 | 2.775 | 2.564 | 2.495 | 0.527 | 0.406 | 0.317 | 0.247 | 0.258 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.438 | -0.775 | -0.658 | 0 | 0.151 | -0.008 | 0 |
| Stock Based Compensation
| 29.293 | 24.202 | 16.395 | 7.899 | 8.353 | 6.919 | 4.241 | 2.13 | 0.099 | 0.042 |
| Change In Working Capital
| -19.511 | -7.766 | -3.314 | -19.016 | 26.144 | -18.017 | 35.557 | -0.112 | 0.052 | 1.26 |
| Accounts Receivables
| 0 | 4.242 | -0.915 | 3.339 | -0.757 | -2.771 | -1.816 | -1.588 | -0.192 | 0 |
| Inventory
| 0 | -4.242 | 0.915 | -3.339 | 0.757 | 3.853 | 5.53 | 0 | 0 | 0 |
| Accounts Payables
| -2.868 | 2.045 | -1.39 | 0.309 | -3 | 4.43 | 0.091 | -0.115 | 0.898 | 0.179 |
| Other Working Capital
| -16.643 | -9.811 | -1.924 | -19.325 | 29.144 | -23.529 | 31.752 | 0.003 | -0.846 | 1.081 |
| Other Non Cash Items
| -4.375 | -0.549 | 1.83 | 0.781 | -0.557 | 0.206 | 0.625 | 4.719 | 0.083 | 1.769 |
| Operating Cash Flow
| -70.236 | -108.137 | -107.865 | -72.484 | -41.527 | -49.947 | 3.872 | -29.972 | -14.385 | -7.743 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.609 | -0.795 | -1.101 | -0.471 | -0.967 | -0.486 | -0.666 | -0.379 | -0.399 | -0.299 |
| Acquisitions Net
| 0 | -91.468 | 14.759 | 90.494 | 52.743 | 0 | 0 | 0.032 | 0 | 0 |
| Purchases Of Investments
| -191.045 | -214.874 | -286.589 | -280.027 | -166.936 | -71.06 | -39.546 | -73.169 | -7.865 | 0 |
| Sales Maturities Of Investments
| 152.396 | 307.137 | 271.83 | 189.533 | 114.193 | 73.759 | 56.035 | 14.188 | 0 | 0 |
| Other Investing Activites
| 0 | 91.468 | -14.759 | -90.494 | -52.743 | 2.699 | 16.489 | 0.032 | -7.865 | 0 |
| Investing Cash Flow
| -39.258 | 91.468 | -15.86 | -90.965 | -53.71 | 2.213 | 15.823 | -59.328 | -8.264 | -0.299 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | -10.524 | 9.765 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 132.1 | 14.553 | 123.829 | 255.365 | 34.492 | 23.181 | 64.547 | 83.648 | 17.419 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 38.377 | 4.285 | 6.094 | 2.785 | 1.779 | 0.934 | 1.007 | 22.659 | 17.419 | 9.003 |
| Financing Cash Flow
| 170.477 | 18.838 | 129.923 | 247.626 | 46.036 | 24.115 | 65.554 | 106.307 | 17.419 | 9.003 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0.09 | -0.126 | 0.175 | -0.026 | -0.177 | 0.146 | 0.022 | -0.039 | -0.097 |
| Net Change In Cash
| 60.983 | 2.079 | 6.072 | 84.352 | -49.227 | -23.796 | 85.395 | 17.029 | -5.269 | 0.864 |
| Cash At End Of Period
| 186.952 | 125.969 | 123.89 | 117.818 | 33.466 | 82.693 | 106.489 | 21.084 | 4.055 | 9.324 |